标题: 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer [打印本页] 作者: sbzhkim 时间: 2013-9-26 17:34 标题: 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer
题名
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer